Atlas Trials

Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC

Clinical trial NCT06639971 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06639971
Sponsor
Shanghai Zhongshan Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Hepatocellular Carcinoma (HCC)
Start date
2024-11-01
Primary completion
2024-12-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.